Scienture Holdings Reports 216% Revenue Growth for 2025, Despite Stock Decline

lunes, 30 de marzo de 2026, 11:58 am ET1 min de lectura
SCNX--

Scienture Holdings reported a 216% increase in net revenue to $431,609 in 2025, driven by the commercial launch of Arbli and progress with REZENOPY. Gross margin expanded to 76.8%, and the company strengthened its commercial footprint through PBM-led and institutional GPO agreements. Scienture expects continued momentum for Arbli and the planned commercial launch of REZENOPY in 2026.

Scienture Holdings Reports 216% Revenue Growth for 2025, Despite Stock Decline

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios